Chester E. Markwalter
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 2
- Protein Structure and Dynamics 2
-
- Advanced Drug Delivery Systems 5
- Co-authors
- Robert K. Prud’homme (9 shared papers)Robert F. Pagels (5 shared papers)Chang Tian (1 shared paper)Jie Feng (1 shared paper)Kurt D. Ristroph (4 shared papers)Brian K. Wilson (2 shared papers)Martin D. Eastgate (3 shared papers)Keming Zhu (3 shared papers)
- Journals
- The Journal of Organic Chemistry (2 papers)Journal of Visualized Experiments (2 papers)Organic Process Research & Development (1 paper)The Journal of Physical Chemistry B (1 paper)ACS Nano (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Chester E. Markwalter
14 papers receiving 345 citations
Peers
Comparison fields: 5 of 70
- Pharmaceutical Science 82
- Biomaterials 96
- Molecular Medicine 14
- Surfaces, Coatings and Films 19
- Organic Chemistry 70
Countries citing papers authored by Chester E. Markwalter
This map shows the geographic impact of Chester E. Markwalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chester E. Markwalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chester E. Markwalter more than expected).
Fields of papers citing papers by Chester E. Markwalter
This network shows the impact of papers produced by Chester E. Markwalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chester E. Markwalter. The network helps show where Chester E. Markwalter may publish in the future.
Co-authors
The 25 scholars most cited alongside Chester E. Markwalter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 99 | |
| 2 | 2018 | 73 | |
| 3 | 2019 | 61 | |
| 4 | 2020 | 26 | |
| 5 | 2018 | 19 | |
| 6 | 2021 | 17 | |
| 7 | 2019 | 17 | |
| 8 | 2018 | 12 | |
| 9 | 2017 | 6 | |
| 10 | 2017 | 6 | |
| 11 | 2018 | 6 | |
| 12 | 2020 | 4 | |
| 13 | 2019 | 3 | |
| 14 | 2025 | 2 |
About Chester E. Markwalter
Chester E. Markwalter is a scholar working on Molecular Biology, Pharmaceutical Science, Biomaterials, Organic Chemistry and Food Science, having authored 14 papers that have together received 351 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Microfluidic and Bio-sensing Technologies (2 papers), RNA Interference and Gene Delivery (2 papers), Protein Structure and Dynamics (2 papers), Catalytic C–H Functionalization Methods (2 papers), Proteins in Food Systems (2 papers) and Gold and Silver Nanoparticles Synthesis and Applications (2 papers). The work is most often cited by research in Pharmaceutical Science (82 citations), Biomaterials (96 citations), Molecular Medicine (14 citations), Surfaces, Coatings and Films (19 citations) and Organic Chemistry (70 citations). Chester E. Markwalter has collaborated with scholars based in United States and Australia. Frequent co-authors include Robert K. Prud’homme, Robert F. Pagels, Chang Tian, Jie Feng, Kurt D. Ristroph, Brian K. Wilson, Martin D. Eastgate, Keming Zhu, Carolyn S. Wei and Yi Hsiao. Their work appears in journals such as The Journal of Organic Chemistry, Journal of Visualized Experiments, Organic Process Research & Development, The Journal of Physical Chemistry B and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.